The answer is in the headline.
I thought you'd be against continued ineffective treatment as it'd be a waste of time and money.
This move - which I agree is abrupt - is ultimately philosophically and logically conservative.
Why?
Based on Centers for Disease Control and Prevention data, the omicron variant of SARS-CoV-2 is estimated to account for more than 99% of cases in the United States as of Jan. 15. Therefore, it’s highly unlikely that COVID-19 patients seeking care in the U.S. at this time are infected with a variant other than omicron, and these treatments are not authorized to be used at this time. This avoids exposing patients to side effects, such as injection site reactions or allergic reactions, which can be potentially serious, from specific treatment agents that are not expected to provide benefit to patients who have been infected with or exposed to the omicron variant.
We agree.
But we then need to follow up and check the footnotes.
Taken from the FDA release: Link.
If you've got 99 percent of folks with Omicron and monoclonal is shown not to be effective, then you shelve it for the time being.
That's my thought.
The only point I'm making is that there are doctors who disagree with the assessment that they're not effective. In the article, the FDA is throwing its weight behind the Glaxo version and dismissing the others, which is at least curious.
It says in the article that Regeneron itself says their version is not as effective against omicron.
On January 7, DeSantis said he'd secured 15,000 doses of Regeneron's antibody treatment for the state, despite the pharmaceutical company saying in December its REGEN-COV antibodies "have diminished potency against Omicron."
I'm fine with your doctor saying it's ineffective. But allowing the govt to step in just stinks to high heaven.
Maroon and White
Mississippi State WBK completes roster with second international addition
Maroon and White
1-on-1: Mississippi State's emerging leaders on both sides of the ball
Maroon and White
Mississippi State Preseason Camp Takeaways
Maroon and White
Mississippi State Baseball adds Jackson, Tenn. fall exhibition date
Maroon and White
Jahron Manning begins search for new team